This post was originally published on this site

Nov. 10 (UPI) — The Dow Jones Industrial Average rose 262 points Tuesday while declining tech stocks dragged the other two major U.S. indexes down.

The blue-chip index climbed 0.9%, continuing a rally that began on election week, while the S&P 500 dropped 0.14% and the Nasdaq Composite fell 1.37%.


Stocks that would benefit from an economic recovery continued to climb as Boeing stock grew 5.2%, Chevron climbed 4.62% and Exxon Mobil increased 2.22%.

Tech stocks however continued a decline as Zoom stock dropped 9.01%, Amazon fell 3.46%, Microsoft declined 3.38% and Google‘s parent company, Alphabet, ended the day down 1.35%.

“The ‘stay at home’ trade, which has led the market higher for most of this year, may be falling out of favor,” Lindsey Bell, chief investment strategist at Ally Invest, told CNBC. “There’s still a good long-term case for tech, but it may not outpace the rest of the market like it has since March.”

The Dow hit a record high early in trading Monday behind the strength of Pfizer and BioNTech stocks after the companies announced their COVID-19 vaccine is about 90% effective, but tech losses capped the gains at 834 points.

Optimism surrounding a vaccine and president-elect Joe Biden‘s virus potential response has helped to drive the market higher but U.S. COVID-19 cases continue to rise as the nation added more than 100,000 cases for the sixth consecutive day Tuesday.

“The pandemic still has a ways to go, unfortunately,” Nick Brooks, head of economic and investment research at Intermediate Capital Group, told The Wall Street Journal. “The Pfizer development is a great development, but I don’t think it’s the game-changer the markets seem to perceive.”